The evolving SARS-CoV-2 epidemic in Africa: Insights from rapidly expanding genomic surveillance

This article has 1 evaluations Published on
Read the full article Related papers
This article on Sciety

Abstract

Investment in Africa over the past year with regards to SARS-CoV-2 genotyping has led to a massive increase in the number of sequences, exceeding 100,000 genomes generated to track the pandemic on the continent. Our results show an increase in the number of African countries able to sequence within their own borders, coupled with a decrease in sequencing turnaround time. Findings from this genomic surveillance underscores the heterogeneous nature of the pandemic but we observe repeated dissemination of SARS-CoV-2 variants within the continent. Sustained investment for genomic surveillance in Africa is needed as the virus continues to evolve, particularly in the low vaccination landscape. These investments are very crucial for preparedness and response for future pathogen outbreaks.

One-Sentence Summary

Expanding Africa SARS-CoV-2 sequencing capacity in a fast evolving pandemic.

Related articles

Related articles are currently not available for this article.